FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 752 - AIDS Research Advisory Committee, NIAID - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	AIDS Research Advisory Committee, NIAID	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	752
Original Establishment Date	11/4/1988	Committee Status	Chartered
Actual Termination Date		Committee URL	https://www.niaid.nih.gov/about/committees-aids...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	16
Terminated This FY	No	Designated Fed Officer Position Title*	Branch Chief, Science Planning and Operations Branch
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	8/23/2023	Designated Federal Officer First Name*	PAMELA
Date Of Renewal Charter	8/23/2025	Designated Federal Officer Middle Name	E.
Projected Termination Date		Designated Federal Officer Last Name*	GILDEN
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority		Designated Federal Officer Phone*	(301) 594-9954
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*	(240) 627-3466
Specific Establishment Authority*	42USC300cc-3	Designated Federal Officer Email*	pamela.gilden@nih.gov
Effective Date Of Authority*	11/4/1988
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	This committee is composed of highly qualified scientists with expertise related to the Institute’s HIV/AIDS research efforts. It provides a breadth and balance of specialized knowledge necessary to assess the long-range goals, program concepts, research opportunities, and direction of ongoing research and future plans, including HIV pathogenesis, epidemiology, vaccine, prevention and treatment research.
How is membership balanced?*	The AIDS Research Advisory Committee, NIAID has 16 members as follows: Up to 13 voting members with medical and scientific expertise and community perspective appropriate to the Committee’s charge and will include physicians whose clinical practice includes a significant number of patients with AIDS and 3 non-voting ex officio members. Some committee members also have experience/expertise in international HIV research, which is critical given the global nature of NIAID’s research agenda. Community/public representatives are also on the committee. The 3 non-voting ex officio members of this Committee may include: one employee from the Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention to be selected by that organization; a National Institutes of Health (NIH) intramural scientist engaged in clinical research; and the Director, Office of AIDS Research, NIH. Each ex officio member will also be a physician with a clinical practice that includes a significant number of patients with AIDS. A member of the Office of AIDS Research Advisory Council, NIH will also attend and act as liaison representative to ensure adequate communication on critical issues of concern to both advisory Committees.
How frequent & relevant are cmte mtgs?*	The committee met three times during this reporting period and provided valuable advice to the Division of AIDS (DAIDS), evaluating current activities and reviewing plans for future research projects. The committee also reviewed and approved numerous concepts for new initiatives proposed by DAIDS staff.
Why advice can't be obtained elsewhere?*	This committee is composed of recognized experts in biomedical and/or behavioral research who represent the forefront of research and technical knowledge and public member(s) representing those with HIV infection and/or AIDS. Their recommendations cannot be obtained from other sources because the complex nature of research requires a specialized balance and breadth of objective expertise not otherwise available.
Why close or partially close meetings?	N/A
Recommendation Remarks	Reports: This committee did not produce any public reports during the fiscal year. The DFO and Decision Maker positions are held by the same individual because of the way the Institute assigns duties and has delegated authority. The Charter allows the Committee to have 16 authorized members including but not limited to SGEs and Ex-Officios. There are three current Ex-Officios named in the Charter (Diana Finzi, Henry Masur, and Robyn Neblett Fanfair), which equals to the total of 16 Max number of members. Elaine Abrams served as Acting Chair.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	Yes
Outcome Increased Customer Satisfaction	No	Action Comment	The Committee makes recommendations to the Director, NIAID, and the Director, DAIDS, in all areas of biomedical research on HIV infection and AIDS related to the mission of DAIDS, including pathogenesis, natural history and transmission of HIV disease, and those efforts which support progress in its detection, treatment, and prevention. Federal officials at NIH did not implement any changes.
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new way to treat and prevent diseases.	Grants Review Comment	NA
Number Of Recommendations*	327	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	The Committee advises and makes recommendations to the Director, NIAID, and the Director, DAIDS, in all areas of biomedical research on HIV infection and AIDS related to the mission of DAIDS, including pathogenesis, natural history and transmission of HIV disease, and those efforts which support progress in its detection, treatment, and prevention. The Committee provides broad scientific, programmatic, and budgetary advice on all aspects of HIV-related research supported by NIAID, including fundamental basic and clinical research, discovery and development of vaccines and other preventative interventions, and training of researchers in these activities. This includes the review of progress and productivity of ongoing efforts, assistance in identifying critical gaps/obstacles to progress, and approval of concepts for new initiatives. The Committee made 13 recommendations in FY24.	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Due to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	Due to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.	Access Other	No
Agency Feedback*	Yes	Access Comment	IC Committee Management Officer
Agency Feedback Comment*	Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.	Narrative Description*	NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. NIH works toward that mission by fostering research projects relating to AIDS in order that research in this area world-wide will continue to find new solutions to the treatment and future cure of AIDS.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:21 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Health Care Public Health Treatment Medicine Health and Health Research

Custom Links

Committee Level Reports